Genetics of Differences of Sex Development and Hypospadias
Primary Purpose
Disorders of Sex Development, Hypospadias
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Return of Genetic Results
Sponsored by
About this trial
This is an interventional diagnostic trial for Disorders of Sex Development focused on measuring Exome Sequencing
Eligibility Criteria
Inclusion Criteria:
- Genital or gonadal abnormalities as evidenced by physical examination or imaging (including but not limited to hypospadias, microphallus, clitoromegaly, ambiguous genitalia), with no cause identified by standard clinical evaluation
Exclusion Criteria:
- Inability to provide informed consent
Sites / Locations
- Boston Children's Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Genetic Testing
Arm Description
Subjects will provide a DNA sample, which will be screened for variants in genes related to DSD/hypospadias. Probands/parents who wish to receive results of genetic testing related to DSD/hypospadias will receive these results directly from the research study. Parents who receive results of genetic testing for probands 17 years old or younger will complete questionnaires at the time of enrollment, right after receiving genetic results, and 3 months after receiving genetic results.
Outcomes
Primary Outcome Measures
Decision Regret
Score on Decision Regret Scale
Secondary Outcome Measures
Parenting-Related Stress
Score on Parenting Stress Index
Child Health-Related Stress
Score on Child Health Worry Scale
Anxiety
Score on Generalized Anxiety Disorder-7
Depression
Score on Patient Health Questionnaire-9
Partner Relationship
Score on Kansas Marital Satisfaction Scale
Partner Blame
Score on this novel measure
Stigma
Score on Questionnaire, "Stigma Related to Having a Child with a Urogenital Condition"
Quality of Life score
Score on Questionnaire, "Quality of Life Related to Having a Child with a Urogenital Condition"
Full Information
NCT ID
NCT03102554
First Posted
March 27, 2017
Last Updated
July 20, 2023
Sponsor
Boston Children's Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03102554
Brief Title
Genetics of Differences of Sex Development and Hypospadias
Official Title
Utilizing Whole Exome Sequencing and Genomics to Improve Our Understanding of Differences of Sex Development (DSD) and Hypospadias
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
January 1, 2018 (Actual)
Primary Completion Date
December 2025 (Anticipated)
Study Completion Date
December 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Boston Children's Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study seeks to identify genetic causes of conditions that affect the gonads and genitals, and to study the impact on families of receiving genetic results.
Detailed Description
This study seeks to understand the genetic causes of conditions that affect the development of the genitals, such as differences of sex development (DSD) and hypospadias, and the impact on families of receiving genetic results. The investigators are recruiting individuals with DSD and/or hypospadias without a clear genetic cause along with their family members for our research study. The investigators will collect samples for genetic studies. The investigators will review the clinical record for history, labs and physical exam information. The investigators will also build a tissue bank of blood, urine, and discarded tissues from surgeries. The investigators will return results of genetic testing to parents/guardians of children with DSD/hypospadias and have them complete questionnaires to assess the impact of receiving these results.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Disorders of Sex Development, Hypospadias
Keywords
Exome Sequencing
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Longitudinal cohort
Masking
None (Open Label)
Allocation
N/A
Enrollment
300 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Genetic Testing
Arm Type
Experimental
Arm Description
Subjects will provide a DNA sample, which will be screened for variants in genes related to DSD/hypospadias. Probands/parents who wish to receive results of genetic testing related to DSD/hypospadias will receive these results directly from the research study. Parents who receive results of genetic testing for probands 17 years old or younger will complete questionnaires at the time of enrollment, right after receiving genetic results, and 3 months after receiving genetic results.
Intervention Type
Genetic
Intervention Name(s)
Return of Genetic Results
Intervention Description
The results of testing for genetic causes of DSD/hypospadias will be returned to parents of subjects who elect to receive these results.
Primary Outcome Measure Information:
Title
Decision Regret
Description
Score on Decision Regret Scale
Time Frame
3 months after return of genetic results
Secondary Outcome Measure Information:
Title
Parenting-Related Stress
Description
Score on Parenting Stress Index
Time Frame
3 months after return of genetic results compared to baseline
Title
Child Health-Related Stress
Description
Score on Child Health Worry Scale
Time Frame
3 months after return of genetic results compared to baseline
Title
Anxiety
Description
Score on Generalized Anxiety Disorder-7
Time Frame
3 months after return of genetic results compared to baseline
Title
Depression
Description
Score on Patient Health Questionnaire-9
Time Frame
3 months after return of genetic results compared to baseline
Title
Partner Relationship
Description
Score on Kansas Marital Satisfaction Scale
Time Frame
3 months after return of genetic results compared to baseline
Title
Partner Blame
Description
Score on this novel measure
Time Frame
3 months after return of genetic results compared to baseline
Title
Stigma
Description
Score on Questionnaire, "Stigma Related to Having a Child with a Urogenital Condition"
Time Frame
baseline, 3 months after return of genetic results
Title
Quality of Life score
Description
Score on Questionnaire, "Quality of Life Related to Having a Child with a Urogenital Condition"
Time Frame
baseline, 3 months after return of genetic results
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Genital or gonadal abnormalities as evidenced by physical examination or imaging (including but not limited to hypospadias, microphallus, clitoromegaly, ambiguous genitalia), with no cause identified by standard clinical evaluation
Exclusion Criteria:
Inability to provide informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yee-Ming Chan, MD, PhD
Organizational Affiliation
Boston Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Boston Children's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Genetics of Differences of Sex Development and Hypospadias
We'll reach out to this number within 24 hrs